BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 22895515)

  • 1. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
    Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
    Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Foster MC; Coresh J; Hsu CY; Xie D; Levey AS; Nelson RG; Eckfeldt JH; Vasan RS; Kimmel PL; Schelling J; Simonson M; Sondheimer JH; Anderson AH; Akkina S; Feldman HI; Kusek JW; Ojo AO; Inker LA;
    Am J Kidney Dis; 2016 Jul; 68(1):68-76. PubMed ID: 26948990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular calcification in patients with nondialysis CKD over 3 years.
    Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uremic toxicity and sclerostin in chronic kidney disease patients.
    Desjardins L; Liabeuf S; Oliveira RB; Louvet L; Kamel S; Lemke HD; Vanholder R; Choukroun G; Massy ZA;
    Nephrol Ther; 2014 Nov; 10(6):463-70. PubMed ID: 25070604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations among Serum Beta 2 Microglobulin, Malnutrition, Inflammation, and Advanced Cardiovascular Event in Patients with Chronic Kidney Disease.
    Wu HC; Lee LC; Wang WJ
    J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27645611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.
    Kim CS; Bae EH; Ma SK; Park SK; Lee JY; Chung W; Lee K; Kim YH; Oh KH; Ahn C; Kim SW;
    Clin Exp Nephrol; 2017 Aug; 21(4):608-616. PubMed ID: 27514393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
    Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
    Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?
    Liabeuf S; Glorieux G; Lenglet A; Diouf M; Schepers E; Desjardins L; Choukroun G; Vanholder R; Massy ZA;
    PLoS One; 2013; 8(6):e67168. PubMed ID: 23826225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremia-related oxidative stress in leukocytes is not triggered by β2-microglobulin.
    Neirynck N; Glorieux G; Boelaert J; Schepers E; Liabeuf S; Dhondt A; Massy Z; Vanholder R
    J Ren Nutr; 2013 Nov; 23(6):456-63. PubMed ID: 24016624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiography to predict adverse cardiac and vascular events in patients with severe chronic kidney disease (stage 4): a prospective study.
    Lesaffre F; Wynckel A; Nazeyrollas P; Rieu P; Metz D
    Arch Cardiovasc Dis; 2013 Apr; 106(4):220-7. PubMed ID: 23706368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.
    Yoda S; Nakanishi K; Tano A; Kasamaki Y; Kunimoto S; Matsumoto N; Sato Y; Hirayama A
    J Cardiol; 2012 Nov; 60(5):377-82. PubMed ID: 22890072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients.
    Obokata M; Negishi K; Sunaga H; Ishida H; Ito K; Ogawa T; Iso T; Ando Y; Kurabayashi M
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease.
    Kinoshita T; Asai T; Suzuki T
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):315-21.e3. PubMed ID: 26142149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Yamamoto S
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
    Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.
    De Nicola L; Minutolo R; Chiodini P; Borrelli S; Zoccali C; Postorino M; Iodice C; Nappi F; Fuiano G; Gallo C; Conte G;
    Kidney Int; 2012 Aug; 82(4):482-8. PubMed ID: 22622495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
    Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
    Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and significance of abdominal aortic calcification in chronic kidney disease.
    Hanada S; Ando R; Naito S; Kobayashi N; Wakabayashi M; Hata T; Sasaki S
    Nephrol Dial Transplant; 2010 Jun; 25(6):1888-95. PubMed ID: 20061316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.